Delivery Order SPE2DB24D2101-SPE2DB25FKNXG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $71,873.56 to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count units) on September 29, 2025, with completion targeted for October 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count) valued at $35,936.78 on September 18, 2025. This firm fixed-price delivery order, which is not subject to any set-aside designation, is scheduled for completion by October 9, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count units) valued at $17,968.39. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of August 29, 2025. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count supply) on October 31, 2025, with an ultimate completion date of November 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under a...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count units) under a firm fixed price contract type. This competitive award, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $18,935.93 delivery order to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count) on December 3, 2025, with an ultimate completion date of December 24, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical procurement under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is listed as AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $35,936.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count supply) on September 18, 2025, with an ultimate completion date of October 9, 2025. The award is unclassified as a set-aside contract and represents a competitive procurement action. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city. The delivery order...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $17,368.14 contract is for the provision of WELIREG 40 MG TABLET 90S, a prescription pharmaceutical product, with a completion date of February 27, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a global pharmaceutical sourcing and distribution services company that has received numerous...
- The Defense Logistics Agency awarded a delivery order valued at $18,935.93 to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 5, 2025. The award was made on November 13, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This federal contract award is a Delivery Order valued at $17,968.39, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WELIREG 40 MG TABLET 90S, a prescription medication, with a performance period ending on June 17, 2025. The contract is a Firm Fixed Price arrangement, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNXGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for WELIREG 40 mg tablets (90-count supply) on August 26, 2025, with completion scheduled for September 17, 2025. This firm fixed-price delivery order represents a non-competitive award under a larger contract vehicle and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, continues to fulfill the DLA's pharmaceutical procurement needs through this transaction. This delivery order is executed under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's established position as a pharmaceutical prime vendor demonstrates its capacity to meet federal medical supply requirements through open competition and flexible contracting mechanisms designed to support defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.0k | 8/26/25 |